SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer reports 4% rise in Q3 net profit

31 Jan 2017 Evaluate

Pfizer has reported results for third quarter ended December 31, 2016. 

The company has reported 4.37% rise in its net profit at Rs 62.37 crore for the quarter under review as compared to Rs 59.76 crore for the same quarter in the previous year. However, total income of the company decreased by 2.58% at Rs 536.75 crore for the quarter under review as compared Rs 550.96 crore for the corresponding quarter previous year. 

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4853.90 42.85 (0.89%)
11-May-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.10
Dr. Reddys Lab 1289.65
Cipla 1326.30
Zydus Lifesciences 946.80
Lupin 2263.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×